3.84 DLBCL, Bad Cancer Drugs and Bad Twitter Users with Dr. Aaron Goodman

from Plenary Session - inactive due to federal service · host Vinay Prasad, MD MPH

We're joined today by Dr. Aaron Goodman, a hematologist/oncologist at the University of California San Diego, to discuss diffuse large B-cell lymphoma (DLBCL). We talk about bad cancer drugs and bad Twitter users. Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

Episode metadata supplied by the publisher feed · Published May 26, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

3.84 DLBCL, Bad Cancer Drugs and Bad Twitter Users with Dr. Aaron Goodman

0:00 1:11:31

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Plenary Session - inactive due to federal service?

This episode is 1 hour and 11 minutes long.

When was this Plenary Session - inactive due to federal service episode published?

This episode was published on May 26, 2021.

Can I download this Plenary Session - inactive due to federal service episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!